Global pharma company with U.S. HQ in Atlanta to make nearly $2B acquisition

UCB has agreed to buy Zogenix, a California-based biopharmaceutical company that develops treatments for rare diseases.

Source: bizjournals.com Health Care:Biotechnology headlines - January 19, 2022 Category: Biotechnology Authors: Maegan Smith Source Type: news